FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/039058 [Registered on: 30/12/2021] Trial Registered Prospectively
Last Modified On: 29/12/2021
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Aqueous outflow anomaly in childhood and adult glaucomas 
Scientific Title of Study   Aqueous angiography in congenital, high pressure juvenile glaucoma and adult onset glaucomas 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
IEC-681/01.10.2021  Other 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  SHIKHA GUPTA 
Designation  Associate Professor 
Affiliation  Dr. R. P Centre, All India Institute of Medical Sciences 
Address  7 floor Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, NEW DELHI

New Delhi
DELHI
110029
India 
Phone  09910015999  
Fax    
Email  dr.shikhagupta84@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  SHIKHA GUPTA 
Designation  Associate Professor 
Affiliation  Dr. R. P Centre, All India Institute of Medical Sciences 
Address  7 floor Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, NEW DELHI
7 floor Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, NEW DELHI
New Delhi
DELHI
110029
India 
Phone  09910015999  
Fax    
Email  dr.shikhagupta84@gmail.com  
 
Details of Contact Person
Public Query
 
Name  SHIKHA GUPTA 
Designation  Associate Professor 
Affiliation  Dr. R. P Centre, All India Institute of Medical Sciences 
Address  7 floor Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, NEW DELHI

New Delhi
DELHI
110029
India 
Phone  09910015999  
Fax    
Email  dr.shikhagupta84@gmail.com  
 
Source of Monetary or Material Support  
ARVO 
 
Primary Sponsor  
Name  ARVO 
Address  5515 Security Lane, Suite 500 Rockville, MD 20852-5007 
Type of Sponsor  Other [INTERNATIONAL RESEARCH ORGANISATION] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shikha Gupta  Dr Rajendra Prasad Centre for OPhthalmic Centre  All India Institute of Medical Sciences
South
DELHI 
09910015999

dr.shikhagupta84@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: H408||Other glaucoma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  none  nil 
 
Inclusion Criteria  
Age From  1.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  This will be a pilot study to analyze the aqueous angiographic signals from representative groups of Congenital glaucoma, Juvenile open angle glaucoma and Primary open angle glaucoma patients who will be posted for cataract or trabeculectomy surgery in the routine Operation theatre.

Cases: 10 cases each ofCongenital glaucoma, Juvenile open angle glaucoma, Primary open angle glaucoma patientsand controls who will be already posted in the OT for either cataract surgery or filtering glaucoma surgery.
The diagnostic criteria for each of the condition will be defined as below:

Congenital glaucoma
Inclusion criteria for congenital glaucoma will be as follows: untreated/unoperatedcases of congenital glaucoma with enlarged corneal diameters (>12 mm) who are diagnosed with baseline IOP records of >22 mm Hg detected before 3 years of age and are scheduled for IOP lowering surgery under general anaesthesia.

Adult-Onset POAG
These will be unrelated POAG patients diagnosed after the age of 40 years presenting with high baseline IOP>25mmHg, scheduled for IOP lowering/ cataract surgery would be included. Only those eyes that had not undergone previous surgery would be included. They will be diagnosed based on open angle on gonioscopy in both eyes, and glaucomatous optic neuropathy
in one or both eyes with visual field loss consistent with optic nerve damage.

JOAG Patients
These will be unrelated POAG patients diagnosed between 10 and 40 years of age presenting with high baseline IOP>25mmHg, scheduled for IOP lowering/ cataract surgery would be included. Only those eyes that had not undergone previous surgery would be included.
 
 
ExclusionCriteria 
Details  Patients excluded from the study: those with a history of steroid use, presence of any other retinal or neurologic pathology, evidence of secondary causes of raised IOP such as pigment dispersion, pseudoexfoliation, or trauma, those with any pathology detected on gonioscopy such as angle recession, pigmentation of the angle greater than grade 3, irido-trabecular contact or peripheral anterior synechiae, and patients with nystagmus will be excluded.  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
·To establish the aqueous outflow patterns in normal healthy subjects undergoing cataract surgery
· To ascertain the aqueous outflow patterns in glaucomatous eyes with, congenital glaucoma, juvenile onset high pressure glaucomas, and late onset adult primary open angle glaucomas
· To establish phenotypic-functional relationship between the disease severity and the amount of aqueous angiographic signal.
 
It will be assessed at baseline once only as this is a cross sectional study with no follow up required.
 
 
Secondary Outcome  
Outcome  TimePoints 
1. To establish phenotypic-functional relationship between the disease severity and the amount of aqueous angiographic signal.
2. to determine the time delay in hagiographic flow in different groups of subjects. 
It will be assessed at baseline only as this is a cross sectional study with no follow up required. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL out of this present study 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) - 

  6. For how long will this data be available start date provided 02-12-2022 and end date provided 02-12-2025?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Glaucoma involves resistance in aqueous outflow channels which can be either at level of thetrabecular meshwork, conventional outflow channels, Schlemm’s canal, collector channels, aqueous, episcleral vein or further down distally. Histological study, the most common analysis endpoint, is not possible in patients. Therefore, real-time imaging that avoids the need to process tissue for analyses is required. Though histopathological evidence to all this   exists, there was no technology for in vivo visualization of these structures before the advent of aqueous angiography, which was developed by Huang et al in 2017 and is a form of invasive real-time aqueous outflow channel imaging.

As of now, aqueous angiography experiments have been validated in live human non- glaucomatous eyes undergoing cataract surgery using tracer molecules like fluorescein and ICG dye. These experiments have shown segmental pulsatile patterns of aqueous outflow, with maximum flow localized around nasal and inferior segments in normal human eyes. Because fluorescein and ICG are both tracers recommended to stain lens capsule during cataract surgery with no side effects, additional capsular staining was unnecessary following their use. Following the injection of tracer at constant pressure through intracameral infusion, the flow through outflow channels can be visualised through the FLEX arm of Heidelberg Spectralis module which is the standard Spectralis mounted on a surgical boom arm (Heidelberg Inc., Germany).

As the majority of results have been acquired from normal human eyes, there is an unmet need and tremendous potential to better study glaucomatous eyes.  Potential clinical relevance for aqueous angiography has been    established using Minimally Invasive Glaucoma Surgeries (MIGS). MIGS are a new category of glaucoma surgery well known for their ease, speed of surgery, and low risk profile. The most common MIGS are the trabecular-type where the TM is either ablated or bypassed. While successful in lowering IOP, MIGS have shown some inconsistency in their outcomes.

Therefore, aqueous angiography has tremendous potential in demonstrating the real-time dysgenesis and pathophysiology of AHO channels that is present in congenital, developmental and adult-onset glaucomas. This research can uncover the reason for ocular hypertension in these subjects. Hence we aim to apply aqueous angiography in different subsets of glaucoma eyes. This information can potentially open up new avenues for glaucoma therapy development in these eyes with potentially refractory disease.


Objectives

·           To establish the aqueous outflow patterns in normal healthy subjects undergoing cataract surgery

·           To ascertain the aqueous outflow patterns in glaucomatous eyes with, congenital glaucoma,  juvenile onset high pressure glaucomas, and late onset adult primary open angle glaucomas

·           To establish phenotypic-functional relationship between the disease severity and the amount of aqueous angiographic signal

 
Close